CAP TODAY/Astra Zeneca Webinar: The Evolving Role of BRCA Testing in Ovarian Cancer

Thank you

This live web event has ended. Thank you for attending.

Description

The Evolving Role of BRCA
Testing in Ovarian Cancer

Why should you register now for this webinar?
Hear national thought leaders discuss the following topics:

The link between molecular profiles and disease pathogenesis in ovarian cancer
The clinical significance of PARP inhibition in BRCA1 and/or 2–mutated
ovarian cancer
The testing process for BRCA mutations
The evolving paradigms in tumor and germline BRCA testing in ovarian cancer

Brought to you by CAP TODAY
Moderated by Bob McGonnagle, Publisher, CAP TODAY
Presenters: Dana Chase, MD, FACOG and John Longshore, PhD, FACMG
You will have the opportunity to ask questions of our distinguished presenters.

CAP TODAY does not endorse any of the products or services named within.
©2019 AstraZeneca. All rights reserved.

Contributors

Bob McGonnagle

Publisher, CAP TODAY
Dana Chase, MD, FACOG

Assistant Professor,
Division of Gynecologic Oncology
University of Arizona College of Medicine, Phoenix, AZ
Creighton University School of Medicine
at St. Joseph’s Hospital, Phoenix, AZ
Gynecologic Oncologist, Arizona Oncology
(US Oncology Network), multiple locations
John Longshore, PhD, FACMG

John Longshore, PhD, FACMG
Director, Molecular Pathology
Carolinas Pathology Group, Atrium Health